The cover picture shows a novel ICH Q 14 oriented APD approach for federally flexible liquid chromatographic estimation of lapatinib in its dosage form. This approach utilized QRM to identify the CMVs and chemometrics were applied to establish robust DS. C pk index of the studied CAAs was evaluated by utilizing the MCS approach. Further, the APD approach promises enhanced method performance and presents efficient post-approval change control management options throughout the method lifecycle.